BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20493207)

  • 1. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS.
    Kawamata H; Manfredi G
    Mech Ageing Dev; 2010; 131(7-8):517-26. PubMed ID: 20493207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis.
    Parone PA; Da Cruz S; Han JS; McAlonis-Downes M; Vetto AP; Lee SK; Tseng E; Cleveland DW
    J Neurosci; 2013 Mar; 33(11):4657-71. PubMed ID: 23486940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?
    Bacman SR; Bradley WG; Moraes CT
    Mol Neurobiol; 2006 Apr; 33(2):113-31. PubMed ID: 16603792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.
    Nemtsova Y; Steinert BL; Wharton KA
    Mol Cell Neurosci; 2023 Jun; 125():103834. PubMed ID: 36868541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium dysregulation, mitochondrial pathology and protein aggregation in a culture model of amyotrophic lateral sclerosis: mechanistic relationship and differential sensitivity to intervention.
    Tradewell ML; Cooper LA; Minotti S; Durham HD
    Neurobiol Dis; 2011 Jun; 42(3):265-75. PubMed ID: 21296666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction in ALS.
    Cozzolino M; Carrì MT
    Prog Neurobiol; 2012 May; 97(2):54-66. PubMed ID: 21827820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
    Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
    PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications.
    Nakagawa Y; Yamada S
    Eur J Pharmacol; 2021 Feb; 892():173737. PubMed ID: 33220280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?
    Muyderman H; Chen T
    Br J Pharmacol; 2014 Apr; 171(8):2191-205. PubMed ID: 24148000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium Dyshomeostasis and Lysosomal Ca
    Tedeschi V; Petrozziello T; Secondo A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mitochondrial Ca
    Zhong R; Rua MT; Wei-LaPierre L
    J Physiol; 2024 Apr; 602(8):1519-1549. PubMed ID: 38010626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.
    Jaiswal MK; Zech WD; Goos M; Leutbecher C; Ferri A; Zippelius A; Carrì MT; Nau R; Keller BU
    BMC Neurosci; 2009 Jun; 10():64. PubMed ID: 19545440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS.
    Suzuki M; McHugh J; Tork C; Shelley B; Klein SM; Aebischer P; Svendsen CN
    PLoS One; 2007 Aug; 2(8):e689. PubMed ID: 17668067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium: the Darth Vader of ALS.
    Appel SH; Beers D; Siklos L; Engelhardt JI; Mosier DR
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar; 2 Suppl 1():S47-54. PubMed ID: 11465925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients.
    Delic V; Kurien C; Cruz J; Zivkovic S; Barretta J; Thomson A; Hennessey D; Joseph J; Ehrhart J; Willing AE; Bradshaw P; Garbuzova-Davis S
    J Neurosci Res; 2018 Aug; 96(8):1353-1366. PubMed ID: 29732581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice.
    Martin LJ; Gertz B; Pan Y; Price AC; Molkentin JD; Chang Q
    Exp Neurol; 2009 Aug; 218(2):333-46. PubMed ID: 19272377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice.
    Jaiswal MK; Keller BU
    Mol Pharmacol; 2009 Mar; 75(3):478-89. PubMed ID: 19060114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
    Manfredi G; Xu Z
    Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.